The Biotech Startups Podcast

Don't Build Your Own Cathedral: The Hidden Cost of Lab Space | Philip Borden (4/4)

Philip breaks down the hidden costs of traditional lab leases, from equipment maintenance and utilities to medical waste, freezer alarms, and unused square footage. He ex

The Biotech Deal That Became a Leadership Crisis | Philip Borden (3/4)

Philip Borden describes leaving Frazier Healthcare Partners for Harvard Business School, where the case method broadened his perspective beyond healthcare and investing.

Cold Calling Your Way Into Venture Capital | Philip Borden (2/4)

Philip Borden explains how realizing he did not want to pursue a PhD or spend his career at the lab bench led him toward venture capital. With a molecular biology degree,

What Rural Indiana Can Teach Biotech Founders About Trust | Philip Borden (1/4)

Philip Borden grew up in Plymouth, Indiana, in a family shaped by agriculture. He talks about his grandparents' farms, his father's work as an agricultural lender, and th

🧬 Making Lab Data Actionable Through Automation | Nathan Clark Rerelease (4/4)

In this part of the podcast, Nathan Clark explains how Ganymede approaches data integration and automation in life sciences. He discusses why lab instruments and workflow

🧬 Why Wet-Lab Data Needs More Than ETL | Nathan Clark Rerelease (3/4)

Nathan Clark walks through his work at Benchling, where he managed the Insights business intelligence product and helped develop an early machine learning effort. He expl

🧬 Product Thinking, Scientific Progress, & the Work of Building | Nathan Clark Rerelease (2/4)

The conversation then turns to product management. Nathan describes the discipline as understanding why a product should exist, grounding decisions in user needs, and tra

🧬 Execution, Liquidity, & Founder Lessons | Nathan Clark Rerelease (1/4)

Nathan Clark reflects on the formative influence of his entrepreneurial father, who showed him that business and even home building are learned through research, effort,

🧬 AI, Mechanisms, & the Next Wave of Drug Discovery | David Li Rerelease (4/4)

David Li explains how a research question about mischaracterized drug targets became the starting point for Meliora Therapeutics. He describes how CRISPR experiments and

🧬 De-Risking Biotech's Biggest Bets | David Li Rerelease (3/4)

In this part of the podcast, David Li, CEO and co-founder of Meliora Therapeutics, reflects on his experience helping build Everest Detection around the challenge of find

🧬 Choosing Conviction Over Convention in Biotech | David Li Rerelease (2/4)

In this part of the podcast, David Li reflects on leaving finance after realizing that an investing career would not give him the tangible impact he wanted. He explains w

🧬 The Outsider Mindset Behind Successful Biotech Founders | David Li Rerelease (1/4)

In this part of the podcast, David shares how the Roy Vagelos Life Sciences and Management dual degree program at the University of Pennsylvania opened his eyes to the po

🧬 This Ex-Googler Replaced a Whole Drug R&D Team | Javier Tordable (4/4)

In this part of the podcast, Javier Tordable unpacks why he left Google to solo found Pauling AI and how its agentic platform automates computational chemistry—from docki

🧬 From Games to Cancer Research: Why Drug Discovery Is an Economics Problem | Javier Tordable (3/4)

In this part of the podcast, Jon and Javier explore Javier's years as technical director in Google's Office of the CTO, where he worked with the world's biggest gaming co

🧬 16 Years at Google Taught Me How to Scale From 1 to 150 People | Javier Tordable (2/4)

In this part of the podcast, Javier Tordable shares his early career journey—from starting at Microsoft to spending 16 years at Google as a Staff Engineer and Technical D

🧬 Video Games & a Whim Led Me to Microsoft | Javier Tordable (1/4)

In this episode of The Biotech Startups Podcast, Jon Chee sits down with Javier Tordable, founder and CEO of Pauling AI, a company building the first fully autonomous dru

🧬 Crossover Investing, Gene Therapy & LP Trust | Stephanie Sirota Rerelease (3/3)

In this episode of The Biotech Startups Podcast, host Jon Chee continues his conversation with Stephanie Sirota, Partner and Head of Strategic Partnerships at RTW Investm

🧬 Cycles, Conviction & Royalty Capital in Biotech Investing | Stephanie Sirota Rerelease (2/3)

In this episode of The Biotech Startups Podcast, host Jon Chee continues his conversation with Stephanie Sirota, Partner and Head of Strategic Partnerships at RTW Investm

🧬 Competition, Coaching & Curiosity: The Investor’s Mindset | Stephanie Sirota Rerelease (1/3)

In this episode of The Biotech Startups Podcast, Jon Chee sits down with Stephanie Sirota, partner and head of strategic partnerships at RTW Investments, to explore how a

🧬 Transforming Food Systems with Lactoferrin & Precision Fermentation | Fengru Lin Rerelease (3/3)

In this episode of The Biotech Startups Podcast, Jon Chee sits down with Fengru Lin, CEO & co-founder of TurtleTree, who is leveraging precision fermentation and a people